Autobahn Therapeutics, Inc. · 1 day ago
Associate Director/Director, Clinical Science
Autobahn Therapeutics is a biotechnology company developing innovative neuropsychiatric and neuroimmunologic clinical candidates. They are seeking an Associate Director/Director of Clinical Science to drive the strategic planning and execution of clinical programs, leveraging data analysis to inform decision-making and collaborating with cross-functional teams to ensure operational excellence.
Responsibilities
Partner with cross-functional teams (Clinical Operations, Regulatory, Medical Affairs, Biometrics) to optimize study design and protocol development
Review and interpret clinical study data; resolve discrepancies and ensure high data quality and integrity
In collaboration with Biometrics, analyze datasets, QC tables/listings/figures, and deliver fit-for-purpose analyses
Contribute to clinical study reports, regulatory documents, and external publications
Provide scientific support for clinical sites, vendors, and advisory boards
Analyze trial progress and site performance metrics to inform operational and scientific decisions
Support development of clinical materials, including informed consent forms, site training content, and presentations
Qualification
Required
Advanced degree (PhD, PharmD, or equivalent) in life sciences or related field
6+ years of clinical trial experience in biotech or pharma with at least 1 year in small biotech
Strong background in scientific data analysis and interpretation
Working knowledge of clinical trial design, GCP, and regulatory requirements
Experience with EDC systems and data analytics tools
Excellent communication, collaboration, and problem-solving skills
Highly organized with attention to detail and the ability to thrive in a fast-paced, team-oriented environment
Preferred
Experience in neuropsychiatry or neurology drug development
Contributions to both early- and late-phase clinical trials
Familiarity with statistical or data visualization tools (e.g., R, Spotfire, JMP)
Benefits
Medical
Dental
Vision
Life
Disability
401(k) plan with company matching
Discretionary bonus
Equity awards
Company
Autobahn Therapeutics, Inc.
Autobahn Therapeutics is focused on improving life health for people affected by CNS disorders by driving the regenerative power of the human body.
Funding
Current Stage
Growth StageTotal Funding
$208.7MKey Investors
Newpath Management
2024-07-24Series C· $100M
2022-09-08Series Unknown· $32.7M
2020-06-11Series B· $76M
Recent News
Precedence Research
2025-09-22
Company data provided by crunchbase